Cargando…

Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients

To investigate the relationships between Chromosome 7 gain, mesenchymal-epithelial transition factor (MET) gene copy number increase and MET protein overexpression in Chinese patients with papillary renal cell carcinoma (PRCC), immunohistochemistry (IHC), immunofluorescence (IF) and fluorescence in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Xiaolu, Zhang, Tianwei, Su, Xinying, Ji, Yan, Ye, Peng, Fu, Haihua, Fan, Shuqiong, Shen, Yanying, Gavine, Paul R., Gu, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670110/ https://www.ncbi.nlm.nih.gov/pubmed/26636767 http://dx.doi.org/10.1371/journal.pone.0143468

Ejemplares similares

Intra-Tumoral Heterogeneity of HER2, FGFR2, cMET and ATM in Gastric Cancer: Optimizing Personalized Healthcare through Innovative Pathological and Statistical Analysis
por: Ye, Peng, et al.
Publicado: (2015)

MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome
por: Yin, Wei, et al.
Publicado: (2022)

High-level gain of mesenchymal-epithelial transition factor (MET) copy number using next-generation sequencing as a predictive biomarker for MET inhibitor efficacy
por: Wu, Shibo, et al.
Publicado: (2020)

Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2018)

Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
por: Sun, Wenze, et al.
Publicado: (2013)

MET Gene Copy Number Alterations and Expression of MET and Hepatocyte Growth Factor Are Potential Biomarkers in Angiosarcomas and Undifferentiated Pleomorphic Sarcomas
por: Schmitz, Katja, et al.
Publicado: (2015)

Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis
por: Overbeck, Tobias Raphael, et al.
Publicado: (2020)

Clinical Significance of MET Gene Copy Number in Patients with Curatively Resected Gastric Cancer
por: Kang, Byung Woog, et al.
Publicado: (2015)

A Review of Papillary Renal Cell Carcinoma and MET Inhibitors
por: Rhoades Smith, Katherine Emilie, et al.
Publicado: (2019)

Suppression of c-Met-Overexpressing Tumors by a Novel c-Met/CD3 Bispecific Antibody
por: Huang, Lei, et al.
Publicado: (2020)

Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity
por: Zhang, Tianwei, et al.
Publicado: (2015)

Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant Mesothelioma
por: Santoni-Rugiu, Eric, et al.
Publicado: (2021)

Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
por: Chiriaco, Cristina, et al.
Publicado: (2022)

Detection of MET Gene Copy Number in Cancer Samples Using the Droplet Digital PCR Method
por: Zhang, Yanni, et al.
Publicado: (2016)

Association Analysis of MET Gene Polymorphism with Papillary Thyroid Carcinoma in a Chinese Population
por: Ning, Lifeng, et al.
Publicado: (2015)

MET expression and copy number status in clear-cell renal cell carcinoma: prognostic value and potential predictive marker
por: Macher-Goeppinger, Stephan, et al.
Publicado: (2016)

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome
por: Lee, H E, et al.
Publicado: (2012)

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)
por: Casadevall, David, et al.
Publicado: (2015)

Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients
por: Wang, Yanqiu, et al.
Publicado: (2019)

MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases
por: Ma, Shirong, et al.
Publicado: (2018)

A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies
por: Platt, Adam, et al.
Publicado: (2015)

Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer
por: Yung, Man Kuen, et al.
Publicado: (2015)

Papillary carcinoma of the thyroid: methylation is not involved in the regulation of MET expression
por: Scarpino, S, et al.
Publicado: (2004)

Devil in the detail: MET overexpression fails as surrogate marker for MET exon 14 splice site mutations in NSCLC
por: Strickland, Matthew R., et al.
Publicado: (2020)

Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
por: Miyamoto, M, et al.
Publicado: (2011)

Characterizing the roles of Met31 and Met32 in coordinating Met4-activated transcription in the absence of Met30
por: Carrillo, Emilio, et al.
Publicado: (2012)

Centromere 17 copy number gain reflects chromosomal instability in breast cancer
por: Lee, Kyoungyul, et al.
Publicado: (2019)

Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression
por: Durante, Sandra, et al.
Publicado: (2016)

Overexpression of FGFR2 contributes to inherent resistance to MET inhibitors in MET-amplified patient-derived gastric cancer xenografts
por: LIU, KAI, et al.
Publicado: (2015)

SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer
por: Zhou, Ji, et al.
Publicado: (2023)

Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer
por: Minuti, G, et al.
Publicado: (2012)

High MET gene copy number predicted poor prognosis in primary intestinal diffuse large B-cell lymphoma
por: Huang, Wan-Ting, et al.
Publicado: (2013)

Development and interlaboratory evaluation of a NIST Reference Material RM 8366 for EGFR and MET gene copy number measurements
por: He, Hua-Jun, et al.
Publicado: (2019)

Recurrence of ovarian squamous cell carcinoma with MET gene copy number variation: a case report and review of literature
por: Dong, Xuhui, et al.
Publicado: (2020)

The Pathogenetic Role of the HGF/c-Met System in Papillary Carcinoma of the Thyroid
por: Ruco, Luigi, et al.
Publicado: (2014)

Clinicopathological and prognostic significance of c-Met overexpression in breast cancer
por: Zhao, Xixi, et al.
Publicado: (2017)

MET overexpression and intratumor heterogeneity in esophageal squamous cell carcinoma
por: Abboud, H.S., et al.
Publicado: (2021)

Critical Role of MetR/MetB/MetC/MetX in Cysteine and Methionine Metabolism, Fungal Development, and Virulence of Alternaria alternata
por: Gai, Yunpeng, et al.
Publicado: (2021)

Overexpression of miR-101 promotes TRAIL-induced mitochondrial apoptosis in papillary thyroid carcinoma by targeting c-met and MCL-1
por: Zhu, Jie, et al.
Publicado: (2017)

MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma
por: Zhang, Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k8qkt0h240kma568qciahfjc4d